News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC – International Urology Cancer Summit
Arnab Basu/uabmedicine.org
Jan 2, 2025, 19:20

Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC – International Urology Cancer Summit

International Urology Cancer Summit shared an article by Arnab Basu on LinkedIn:

“Advancing Precision Oncology in Metastatic RCC.

New findings highlight the potential of longitudinal ctDNA monitoring as a predictive biomarker for treatment response and progression-free survival in metastatic renal cell carcinoma (RCC).

This study demonstrates high concordance between ctDNA dynamics and clinical outcomes, paving the way for more personalized approaches to therapy and surveillance.

Discover how these insights could impact the future of RCC management.

Read the full study here.”

Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC - International Urology Cancer Summit

Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma.

Authors: Arnab Basu, et al.

 Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC - International Urology Cancer Summit

Arnab Basu cancer ctDNA fight against cancer Global fight against cancer International Urology Cancer Summit metastatic renal cell carcinoma mRCC OncoDaily Oncology Precision Oncology
Special Coverage
Blog
May 28, 2025, 04:13
ASCO25 to Spotlight Evolving Standards in RCC and Urothelial Cancer Care
Insight
May 28, 2025, 03:50
Patrizia Giannatempo: Phase 1/2 Duravelo-1 study
Blog
May 28, 2025, 02:31
Jaume Capdevila: Great discussion on Neuroendocrine Cancer at ASCO25
Blog
May 28, 2025, 00:35
Stephen Chun: Special episode of NRG Oncology on LBA results of BR003 for triple negative breast cancer
Blog
May 27, 2025, 21:32
Paolo Tarantino: PATINA Trial and First-Line Options for HR+/HER2+ MBC
Blog
May 27, 2025, 21:28
Tingting Zhang: Join to discuss patient partnering in managing chronic toxicities of cancer treatment
Opinion
May 27, 2025, 17:55
Amol Akhade: DESTINY-Breast09 is One of ASCO 2025’s Most Anticipated Trials
Blog
May 27, 2025, 17:43
International Summit in Immuno-Oncology is Set for October 2025 in Yerevan - Santé Arménie Medical Academy
Blog
May 27, 2025, 17:11
Marilys Corbex on Two Key Approaches to Improve Early Cancer Detection - Association of European Cancer Leagues
Insight
May 27, 2025, 16:59
Alcohol Intake Linked to Pancreatic Cancer Risk in New Global Study - IARC/WHO
Blog
May 27, 2025, 16:49
Mohamed Emam Sobeih: Clewalva Center for Oncology and Surgery Offers Care by Egypt’s Best Oncology Experts
Oncolibrary
May 27, 2025, 16:46
USA vs Europe: Who Does Cancer Screening Better?